Publicaciones en las que colabora con Salvador Resino García (30)

2011

  1. Cardiovascular risk markers are increased in HIV-infected children with lipodystrophy syndrome

    Journal of Infection

2008

  1. Immunological recovery and metabolic disorders in severe immunodeficiency HIV type 1-infected children on highly active antiretroviral therapy

    AIDS Research and Human Retroviruses, Vol. 24, Núm. 12, pp. 1477-1484

  2. Long-term response to highly active antiretroviral therapy with lopinavir/ritonavir in pre-treated vertically HIV-infected children

    Journal of Antimicrobial Chemotherapy, Vol. 61, Núm. 1, pp. 183-190

2007

  1. Carga viral plasmática en niños infectados por el virus de la inmunodeficiencia humana que reciben tratamiento antirretroviral de gran actividad

    Medicina Clinica, Vol. 128, Núm. 2, pp. 49-51

2006

  1. CD4+ T-cell immunodeficiency is more dependent on immune activation than viral load in HIV-infected children on highly active antiretroviral therapy

    Journal of Acquired Immune Deficiency Syndromes, Vol. 42, Núm. 3, pp. 269-276

  2. Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children

    BMC Infectious Diseases, Vol. 6

  3. Impact of long-term viral suppression in CD4+ recovery of HIV-children on Highly Active Antiretroviral Therapy

    BMC Infectious Diseases, Vol. 6

  4. Interleukin-7 levels before highly active antiretroviral therapy may predict CD4+ T-cell recovery and virological failure in HIV-infected children [5]

    Journal of Antimicrobial Chemotherapy

  5. La terapia combinada puede ser tan efectiva como la terapia antirretroviral de alta eficacia en el control de la carga viral en niños con un sistema inmunitario conservado

    Acta Pediatrica Espanola, Vol. 64, Núm. 8, pp. 377-382

  6. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 Years of follow-up

    Clinical Infectious Diseases, Vol. 42, Núm. 6, pp. 862-869

  7. Low immunologic response to highly active antiretroviral therapy in naive vertically human immunodeficiency virus type 1-infected children with severe immunodeficiency

    Pediatric Infectious Disease Journal, Vol. 25, Núm. 4, pp. 365-368

2004

  1. HIV-infected children with moderate/severe immune-suppression: Changes in the immune system after highly active antiretroviral therapy

    Clinical and Experimental Immunology, Vol. 137, Núm. 3, pp. 570-577

2003

  1. CD8+ T-cell numbers predict the response to antiviral therapy in HIV-1-infected children

    Pediatric Research, Vol. 53, Núm. 2, pp. 309-312

  2. Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children

    Journal of Clinical Immunology, Vol. 23, Núm. 4, pp. 279-289

  3. Recien nacidos con edad gestacional <26 semanas frente a recien nacidos entre las semanas 26-28

    Acta pediátrica española, Vol. 61, Núm. 2, pp. 83

  4. Recién nacidos con edad gestacional <26 semanas frente a recién nacidos entre las semanas 26-28

    Acta Pediatrica Espanola, Vol. 61, Núm. 2, pp. 83-87

  5. Recovery of T-cell subsets after antiretroviral therapy in HIV-infected children

    European Journal of Clinical Investigation, Vol. 33, Núm. 7, pp. 619-627

  6. Viral Load and CD4+ T Lymphocyte Response to Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-Infected Children: An Observational Study

    Clinical Infectious Diseases, Vol. 37, Núm. 9, pp. 1216-1225

2002

  1. Different immune profiles acccording to the immunological and clinical progression in vertically HIV-infected children

    Medicina Clinica, Vol. 118, Núm. 7, pp. 241-246

  2. Dynamics of progression markers in a non-study population of human immunodeficiency virus-1 vertically infected infants with different antiretroviral treatments

    Acta Paediatrica, International Journal of Paediatrics, Vol. 91, Núm. 7, pp. 776-782